Cystic Fibrosis

Cystic fibrosis essentials

  • Cystic fibrosis, or CF, is an inherited condition caused by changes in the CFTR gene. It affects salt and water movement across cells and can produce thick mucus in the lungs, pancreas, and other organs.
  • Newborn screening can identify babies at higher risk, but a positive screen is not the final diagnosis. Sweat chloride testing and sometimes genetic testing confirm or clarify CF.
  • Care is coordinated through a specialist team and may include airway-clearance therapy, inhaled medicines, antibiotics, pancreatic enzymes, nutrition support, and mutation-specific CFTR modulators.
  • A CFTR modulator works only for responsive gene variants and requires individual safety monitoring. It is not interchangeable with another person’s regimen.
  • Severe breathing difficulty, blue or gray color, coughing significant blood, severe chest pain, confusion, dehydration, or symptoms of bowel blockage needs urgent or emergency care.
A patient completes a supervised breathing test while a respiratory therapist and physician review the measurement.
Breathing tests answer specific questions and should be interpreted in the context of the full assessment.

What cystic fibrosis is

Cystic fibrosis is a lifelong genetic disease that affects the CFTR protein, a channel that helps regulate movement of chloride, bicarbonate, salt, and water across cell surfaces. When CFTR function is reduced or absent, secretions can become unusually thick and sticky. The lungs, sinuses, pancreas, intestines, liver, reproductive tract, sweat glands, and other systems can be affected.

CF is not contagious. People are born with the genetic changes that cause it, although symptoms and diagnosis may occur later. The disease varies greatly. Two people with the same gene variants can have different lung function, digestive symptoms, complications, and treatment response.

Modern screening and treatments have changed the course of CF, but it remains a serious multisystem condition. Care is best coordinated by a team experienced in CF rather than separated into unrelated respiratory and digestive visits.

How CF is inherited

CF follows an autosomal recessive inheritance pattern. A person with CF usually has a disease-causing CFTR variant inherited from each biological parent. Parents who each carry one variant are generally healthy carriers. For each pregnancy between two carriers, probability is recalculated; previous children do not change the genetic chance for the next pregnancy.

More than one kind of CFTR variant can cause disease, and variants affect protein function in different ways. Some combinations cause classic CF, while others may lead to milder or organ-specific CFTR-related disorders. A genetic report should be interpreted with clinical findings, sweat testing, and expert variant classification.

Carrier screening can identify many common variants but may not detect every disease-causing change across all ancestries. Genetic counseling can help a person understand residual risk, reproductive options, family testing, and uncertain results without treating a carrier result as a diagnosis.

Possible lung and sinus symptoms

Thick airway mucus can interfere with normal clearance of bacteria and particles. Symptoms may include persistent cough, wheezing, shortness of breath, recurrent chest infections, reduced exercise tolerance, or slow recovery from respiratory illness. Bronchiectasis, a permanent widening and injury of airways, can develop over time.

Chronic sinus inflammation, nasal congestion, headache, reduced smell, and nasal polyps are common. The organisms found in CF airways and their resistance patterns can differ from those in ordinary community pneumonia. Sputum cultures and the person’s previous microbiology help the CF team select treatment.

A change from baseline matters even when there is no fever. Increased cough, darker or greater sputum, breathlessness, reduced appetite, weight loss, fatigue, or lower home lung-function readings may signal a pulmonary exacerbation and should be reported according to the person’s CF action plan.

Digestive, nutritional, and other effects

Thick secretions can block pancreatic ducts and prevent digestive enzymes from reaching the intestine. Pancreatic insufficiency can cause poor weight gain, bulky or greasy stools, abdominal symptoms, and deficiencies of fat-soluble vitamins. Many people need pancreatic enzyme replacement with meals and snacks, but dosing is individualized and excessive dosing can be harmful.

Newborns may develop meconium ileus, a bowel blockage with failure to pass stool and abdominal swelling. Older children and adults can develop distal intestinal obstruction syndrome. Constipation, reflux, liver disease, gallstones, pancreatitis in some pancreatic-sufficient people, and rectal prolapse can also occur.

CF-related diabetes has features of both insulin deficiency and illness-related insulin resistance. It requires CF-specific screening and management. Low bone mineral density, arthritis, kidney stones, salt depletion, and electrolyte disturbances are other possible concerns. Very salty sweat can increase dehydration risk during heat, exercise, fever, or gastrointestinal illness.

When symptoms are urgent

Call emergency services for severe breathing difficulty, blue or gray lips or skin, confusion, fainting, inability to speak in full sentences, severe chest pain, or coughing more than a small streak of blood. The CF team may provide a personal threshold for blood in sputum; follow that plan and seek urgent advice for any new or increasing bleeding.

Urgent assessment is also needed for a markedly swollen or painful abdomen, repeated green vomiting, inability to pass stool or gas, severe dehydration, very low urine output, or profound weakness during heat or illness. These can reflect bowel obstruction, salt depletion, or another complication.

Contact the CF team promptly for fever, rapidly increased cough, falling lung function, reduced oxygen readings compared with the person’s plan, significant weight loss, jaundice, or a medicine reaction. Do not use someone else’s antibiotics or wait for a routine visit when symptoms are moving away from baseline.

Newborn screening and diagnosis

Newborn screening programs test a blood spot for markers that suggest increased CF risk. Exact algorithms differ by location and may include immunoreactive trypsinogen and a panel of CFTR variants. A positive screen does not mean the baby definitely has CF. It signals the need for prompt confirmatory evaluation.

The sweat chloride test measures chloride in sweat collected after stimulating a small area of skin. It is painless apart from mild tingling and should be performed by an experienced, quality-controlled center. Results are interpreted by age and current standards. An intermediate result may require repeat testing, broader genetic analysis, and specialist follow-up.

People not identified through newborn screening can still be diagnosed later because of recurrent respiratory problems, bronchiectasis, pancreatitis, male infertility, nutritional concerns, or family history. Genetic testing can confirm two disease-causing variants, identify eligibility for some modulators, and help family counseling. An uncertain variant alone does not establish CF.

Specialist monitoring

CF centers monitor growth, nutrition, lung symptoms, oxygen, spirometry when age permits, airway cultures, liver health, glucose regulation, bone health, and treatment burden. The schedule varies with age and disease status. Routine visits matter even when a person feels well because declining lung function or nutritional change can begin before obvious symptoms.

Airway samples may grow bacteria that require infection-control precautions. CF clinics often separate people with CF and use specific masking and room procedures to reduce transfer of organisms. These precautions are not a judgment about cleanliness and should be followed even among friends who both have CF.

Vaccination, including respiratory-virus protection recommended for age and risk, is reviewed by the clinical team. Household members can also help reduce exposure by staying current with recommended vaccines and avoiding visits when acutely ill.

Airway-clearance and respiratory treatment

Airway-clearance techniques help move mucus so it can be coughed out. Options include manual percussion, positive expiratory pressure devices, oscillating vests, and structured breathing methods. A respiratory therapist teaches technique and adjusts it for age, symptoms, exercise, surgery, or pregnancy.

Inhaled medicines may open airways, thin mucus, or treat chronic airway infection. Sequence matters because one treatment can prepare the airway for the next. Equipment must be cleaned and disinfected according to CF-team instructions to avoid contamination. Nebulized medicines should not be mixed unless the pharmacy or team confirms compatibility.

Antibiotics may be inhaled, oral, or intravenous depending on the organism, severity, previous response, and resistance. Some are used for a defined exacerbation while others suppress chronic infection. Finishing, monitoring, and adverse-effect plans are specific to the medicine.

CFTR modulators

CFTR modulators improve the quantity or function of CFTR protein for people with particular responsive variants. They can improve lung function, weight, and other outcomes for many eligible patients, but they do not remove the need for specialist monitoring or automatically reverse established organ damage.

Eligibility depends on the exact variant, age, product approval, and current prescribing information. Liver tests, drug interactions, eye monitoring in some children, and other checks may be required. Grapefruit or certain medicines can alter drug levels. Never use a relative’s modulator or change the dose without the CF team.

People without a currently responsive variant still benefit from comprehensive CF care and may be eligible for research. Treatment access and approved indications continue to evolve, so old online lists should not determine eligibility.

Nutrition and digestive care

Nutrition plans often emphasize adequate energy, protein, and salt while considering diabetes, liver disease, kidney concerns, and physical activity. Many people with pancreatic insufficiency use enzymes with all fat- and protein-containing meals and snacks and take clinician-selected fat-soluble vitamins. The dietitian adjusts the plan using growth, weight, stool pattern, laboratory values, and symptoms.

Enzymes should be swallowed as directed and not crushed or held in the mouth. Persistent greasy stool, pain, poor growth, constipation, or rectal symptoms needs review rather than unlimited enzyme increases. Acid suppression or a different formulation may be considered only by the care team.

During heat, exercise, or illness, fluid and salt replacement may need to increase. The correct plan differs for infants, people with high blood pressure, kidney disease, or other conditions. Use the CF team’s written sick-day and hot-weather instructions.

Long-term complications and advanced care

Cardiac, liver, endocrine, bone, fertility, and mental-health needs are part of CF care. Most males with classic CF have congenital absence or blockage of the vas deferens and may need fertility assistance. Females can often conceive, but pregnancy requires coordinated respiratory, nutrition, diabetes, and medication planning.

Anxiety and depression are common in people with CF and caregivers. Screening and treatment can improve quality of life and treatment participation. A demanding regimen should be simplified collaboratively when possible rather than abandoned in silence.

For advanced lung disease, the team may discuss oxygen, noninvasive ventilation, pulmonary rehabilitation, palliative care, or lung transplantation. Early referral allows time to understand eligibility and tradeoffs. Palliative care can support symptoms and goals alongside disease-directed treatment.

Preparing for a CF visit

Bring a current medicine list, airway-clearance schedule, symptoms compared with baseline, home spirometry or oxygen trends if used, stool pattern, appetite, weight change, and missed treatment barriers. Record fever, sputum color or amount, blood, pain, bowel changes, and recent exposures. Bring equipment questions and ask the team to review cleaning technique when uncertain.

Ask which cultures and tests are due, whether the current genetic report supports a modulator, how to recognize an exacerbation, and when to call after hours. Clarify nutrition targets, enzyme timing, diabetes screening, liver and bone monitoring, fertility planning, and emergency thresholds.

Official sources